Seshu Tyagarajan, Ph.D., RAC

Overview

Seshu Tyagarajan, Ph.D., RAC received $916K in total compensation, including $235K in salary, at Candel Therapeutics in 2022.

Source: SEC filing on May 23, 2023.

Related executives

We found five more executives who work or worked at Candel Therapeutics.

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

Francesca Barone

Candel Therapeutics

Chief Scientific Officer

Jason Amello

Candel Therapeutics

Chief Financial Officer

Estuardo inf

Candel Therapeutics

Chief Executive Officer

John Canepa

Candel Therapeutics

Chief Financial Officer

News

You may also like